Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.83 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.40 |
| ▸ | LDHA | P00338 | 1/20 | 0.40 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.40 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.40 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 6/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL29176309 | 1.00 | FFAR3 (0.83) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Benzene SCHEMBL21273380 | 1.00 | FFAR3 (0.83) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Benzene SCHEMBL27364471 | 0.96 | FFAR3 (0.77) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Benzene SCHEMBL27327713 | 0.96 | FFAR3 (0.77) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Benzene SCHEMBL29143211 | 0.96 | FFAR3 (0.77) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Benzene SCHEMBL28212569 | 0.96 | FFAR3 (0.77) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Benzene SCHEMBL28231011 | 0.96 | FFAR3 (0.77) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Benzene SCHEMBL25264854 | 0.93 | FFAR3 (0.71) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Benzene SCHEMBL28724902 | 0.93 | FFAR3 (0.71) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Propionic Acid SCHEMBL11661434 | 0.91 | FFAR3 (1.00) | FFAR3HDAC3HDAC1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 507 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119998382-A | Flame retardant compositions comprising polycycloolefinic polymers containing olefinic functionality for forming low loss films with improved dielectric and thermal properties | 普罗米鲁斯有限责任公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119890264-A | Negative electrode material of lithium ion battery, preparation method of negative electrode material and battery | 贝特瑞新材料集团股份有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-119890265-A | Negative electrode material of lithium ion battery, preparation method of negative electrode material and battery | 贝特瑞新材料集团股份有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-118955509-B | Targeting near infrared fluorescent compound and preparation method and application thereof | 南京诺源医疗器械有限公司 | 2025-03-04 | — | — | CN | claimed |
| CN-119092691-B | Negative electrode material, preparation method thereof and battery | 贝特瑞新材料集团股份有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-118652257-B | Targeting near infrared fluorescent compound and preparation method and application thereof | 南京诺源医疗器械有限公司 | 2024-12-31 | — | — | CN | claimed |
| CN-119092691-A | Negative electrode material, preparation method thereof and battery | 贝特瑞新材料集团股份有限公司 | 2024-12-06 | — | — | CN | claimed |
| CN-118955509-A | Targeting near infrared fluorescent compound and preparation method and application thereof | 南京诺源医疗器械有限公司 | 2024-11-15 | — | — | CN | claimed |
| CN-116178700-B | PEGylated indocyanine dye coupled taxol prodrug type compound and preparation and application thereof | 沈阳药科大学 | 2024-11-01 | — | — | CN | claimed |
| CN-118652257-A | Targeting near infrared fluorescent compound and preparation method and application thereof | 南京诺源医疗器械有限公司 | 2024-09-17 | — | — | CN | claimed |
| US-20040023890-A1 | Drugs for diabetes | NICOX S.A. (FR) | 2004-02-05 | — | — | US | claimed |
| EP-1324974-A2 | DRUGS FOR DIABETES | Nicox S.A. (FR) | 2003-07-09 | — | — | EP | claimed |
| WO-2002030867-A2 | DRUGS FOR DIABETES | NICOX S.A. (FR) | 2002-04-18 | — | — | WO | claimed |
| EP-0856035-B1 | NON-YELLOWING TAPE ARTICLE | MINNESOTA MINING & MFG (US) | 2000-03-01 | — | — | EP | claimed |
| WO-1999019397-A1 | STABILIZED POLYOLEFIN | DSM N.V. (NL) | 1999-04-22 | — | — | WO | claimed |
| EP-0909797-A1 | Stabilizers for vinyl ether-based coating systems | AlliedSignal Inc. (US) | 1999-04-21 | — | — | EP | claimed |
| EP-0636654-B1 | Block copolymer composition, a process for its preparation and a hot melt adhesive comprising said composition | SHELL INT RESEARCH (NL) | 1997-10-01 | — | — | EP | claimed |
| EP-0773977-A1 | COUPLING AGENTS FOR VINYL ETHER-BASED COATING SYSTEMS | AlliedSignal Inc. (US) | 1997-05-21 | — | — | EP | claimed |
| US-5491178-A | STABILIZING, INHIBITING THE DEHYDROGENATION BY APPLYING A COATING MIXTURE COMPRISING HINDERED PHENOLS, ORGANIC SULFIDES OR DISULFIDES AND TRANSITION METAL SALTS OR COMPLEXES | ALLIEDSIGNAL INC. (US) | 1996-02-13 | — | — | US | claimed |
| WO-1996002596-A1 | COUPLING AGENTS FOR VINYL ETHER-BASED COATING SYSTEMS | ALLIEDSIGNAL INC. (US) | 1996-02-01 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040023890-A1 | Drugs for diabetes | SLC5A2, ADORA2B, UGT2B7 | FFAR3 1232/4885HDAC3 1794/4885HDAC1 1595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.